New Key Statistics Module, Z-Score and F-Score
NYSE:BIO Key Ratios
| Market Cap $ M | 10,246.21 |
| Enterprise Value $ M | 10,013.24 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 35.48 |
| Forward PE Ratio | 32.61 |
| Price/Book | 1.39 |
| Price/Sales | 4.10 |
| Price/Free Cash Flow | 47.12 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2,580.00 |
| EPS (TTM) $ | -27.33 |
| Beneish M-Score | -2.45 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -10.47 |
| EV-to-EBITDA | -12.42 |
| PEG | -- |
| Shares Outstanding M | 28.00 |
| Net Margin (%) | -30.18 |
| Operating Margin % | 11.86 |
| Pre-tax Margin (%) | -38.96 |
| Quick Ratio | 4.52 |
| Current Ratio | 6.14 |
| ROA % (ttm) | -6.82 |
| ROE % (ttm) | -9.62 |
| ROIC % (ttm) | 2.51 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.28 |
BIO Number of Guru Trades
BIO Volume of Guru Trades
Gurus Latest Trades with NYSE:BIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:BIO is held by these investors
Total 6
Bio-Rad Laboratories Inc Insider Transactions
No Available Data
News about NYSE:BIO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers